Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 551
5
Diseases
11
Unique genes
0.219
Avg. similarity score
Lupus
Most-connected disease (4 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Lupus
C2 deficiency
Immunodeficiency due to c1, c4, or c2 component complement deficiency
Irritant dermatitis
Immunodeficiency, common variable, 7
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Lupus | 4 | 4 | 3 |
| C2 deficiency | 3 | 3 | 1 |
| Immunodeficiency due to c1, c4, or c2 component complement deficiency | 3 | 3 | 1 |
| Irritant dermatitis | 3 | 3 | 9 |
| Immunodeficiency, common variable, 7 | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| C2 | 4 / 5 | C2 deficiency, Immunodeficiency due to c1, c4, or c2 component complement deficiency, Irritant dermatitis, Lupus |
| CR2 | 2 / 5 | Immunodeficiency, common variable, 7, Lupus |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Interferon gamma signaling | Reactome | 4 / 87 | 50.2× | 8.15e-7 | 3.48e-5 ✓ sig. |
| Staphylococcus aureus infection | KEGG | 3 / 99 | 33.1× | 8.55e-5 | 1.68e-3 ✓ sig. |
| Hematopoietic cell lineage | KEGG | 3 / 100 | 32.8× | 8.81e-5 | 1.72e-3 ✓ sig. |
| Translocation of ZAP-70 to Immunological synapse | Reactome | 2 / 19 | 115× | 1.29e-4 | 2.32e-3 ✓ sig. |
| Phosphorylation of CD3 and TCR zeta chains | Reactome | 2 / 22 | 99.3× | 1.74e-4 | 2.95e-3 ✓ sig. |
| PD-1 signaling | Reactome | 2 / 23 | 94.9× | 1.91e-4 | 3.16e-3 ✓ sig. |
| Systemic lupus erythematosus | KEGG | 3 / 140 | 23.4× | 2.39e-4 | 3.77e-3 ✓ sig. |
| Generation of second messenger molecules | Reactome | 2 / 31 | 70.4× | 3.50e-4 | 5.06e-3 ✓ sig. |
| Asthma | KEGG | 2 / 32 | 68.2× | 3.73e-4 | 5.32e-3 ✓ sig. |
| Allograft rejection | KEGG | 2 / 39 | 56.0× | 5.55e-4 | 7.25e-3 ✓ sig. |
| Type I diabetes mellitus | KEGG | 2 / 44 | 49.6× | 7.07e-4 | 8.71e-3 ✓ sig. |
| Epstein-Barr virus infection | KEGG | 3 / 204 | 16.1× | 7.21e-4 | 8.84e-3 ✓ sig. |
| Graft-versus-host disease | KEGG | 2 / 45 | 48.5× | 7.39e-4 | 9.01e-3 ✓ sig. |
| Regulation of Complement cascade | Reactome | 2 / 47 | 46.5× | 8.06e-4 | 9.61e-3 ✓ sig. |
| Intestinal immune network for IgA production | KEGG | 2 / 50 | 43.7× | 9.12e-4 | 1.06e-2 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| innate immune response | GO:0045087 | 5 / 605 | 14.0× | 1.37e-5 | 6.97e-4 ✓ sig. |
| antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | GO:0002504 | 2 / 15 | 227× | 3.29e-5 | 1.35e-3 ✓ sig. |
| peptide antigen assembly with MHC class II protein complex | GO:0002503 | 2 / 16 | 212× | 3.76e-5 | 1.49e-3 ✓ sig. |
| host-mediated suppression of symbiont invasion | GO:0046597 | 2 / 24 | 142× | 8.63e-5 | 2.77e-3 ✓ sig. |
| immune system process | GO:0002376 | 5 / 943 | 9.0× | 1.16e-4 | 3.44e-3 ✓ sig. |
| antigen processing and presentation of exogenous peptide antigen via MHC class II | GO:0019886 | 2 / 31 | 110× | 1.45e-4 | 4.04e-3 ✓ sig. |
| complement activation, classical pathway | GO:0006958 | 2 / 37 | 91.8× | 2.07e-4 | 5.22e-3 ✓ sig. |
| positive regulation of immune response | GO:0050778 | 2 / 40 | 84.9× | 2.43e-4 | 5.82e-3 ✓ sig. |
| positive regulation of T cell activation | GO:0050870 | 2 / 45 | 75.5× | 3.08e-4 | 6.90e-3 ✓ sig. |
| antigen processing and presentation | GO:0019882 | 2 / 48 | 70.8× | 3.50e-4 | 7.49e-3 ✓ sig. |
| negative regulation of interleukin-2-mediated signaling pathway | GO:1902206 | 1 / 1 | 1,699× | 5.89e-4 | 1.06e-2 ✓ sig. |
| negative regulation of positive thymic T cell selection | GO:1902233 | 1 / 1 | 1,699× | 5.89e-4 | 1.06e-2 ✓ sig. |
| erythrocyte differentiation | GO:0030218 | 2 / 65 | 52.3× | 6.42e-4 | 1.11e-2 ✓ sig. |
| positive regulation of T cell proliferation | GO:0042102 | 2 / 67 | 50.7× | 6.82e-4 | 1.17e-2 ✓ sig. |
| positive regulation of type II interferon production | GO:0032729 | 2 / 77 | 44.1× | 9.00e-4 | 1.38e-2 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| C2 deficiency | Immunodeficiency due to c1, c4, or c2 component complement deficiency | 0.500 | 1 | 6.46e-5 | 1.98e-4 ✓ sig. |
| C2 deficiency | Lupus | 0.250 | 1 | 1.94e-4 | 4.41e-4 ✓ sig. |
| Immunodeficiency due to c1, c4, or c2 component complement deficiency | Lupus | 0.250 | 1 | 1.94e-4 | 4.41e-4 ✓ sig. |
| Immunodeficiency, common variable, 7 | Lupus | 0.250 | 1 | 1.94e-4 | 4.41e-4 ✓ sig. |
| C2 deficiency | Irritant dermatitis | 0.100 | 1 | 5.81e-4 | 1.00e-3 ✓ sig. |
| Immunodeficiency due to c1, c4, or c2 component complement deficiency | Irritant dermatitis | 0.100 | 1 | 5.81e-4 | 1.00e-3 ✓ sig. |
| Irritant dermatitis | Lupus | 0.083 | 1 | 1.74e-3 | 2.42e-3 ✓ sig. |